首页 > 最新文献

Acta Biomaterialia最新文献

英文 中文
A unified finite element framework for cardiac growth and remodeling in mitral regurgitation incorporating fiber reorientation and baroreflex 二尖瓣返流心脏生长和重构的统一有限元框架,包括纤维重定向和压力反射。
IF 9.6 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2026-01-01 DOI: 10.1016/j.actbio.2025.12.012
Mohammad Mehri , Jonathan F. Wenk
Mitral regurgitation (MR) triggers complex cardiac remodeling responses that alter the structure and function of the left ventricle (LV). While several models have been developed to predict myocardial growth in MR, they often neglect key concurrent adaptive mechanisms that influence both the pattern and severity of LV dilation. This study presents a unified finite element framework to systematically evaluate the individual and combined contributions of fiber reorientation (FR) and baroreflex regulation to LV growth and remodeling, along with the effects of myocardial material property changes associated with the acute and chronic phases of MR. A healthy baseline model and multiple MR models were simulated, each incorporating different combinations of these mechanisms. The growth model that included both FR and baroreflex most accurately reproduced clinical measurements of LV geometry, myocardial mass, and pressure-volume loops. Excluding either FR or baroreflex consistently led to underestimation of myocardial growth and less realistic LV shapes. Importantly, FR was essential for capturing the increased chamber sphericity observed in MR, while baroreflex significantly influenced the extent of dilation and pressure compensation. Phase-dependent changes in myocardial material properties further modulated remodeling patterns, capturing distinct features of acute and chronic disease stages. These findings highlight the critical role of integrating concurrent physiological mechanisms to reliably predict cardiac adaptation in MR and provide new insights into the drivers of remodeling patterns observed in patients. This comprehensive approach offers a valuable framework for evaluating therapies that target distinct aspects of cardiac adaptation.

Statement of Significance

Mitral regurgitation triggers remodeling responses that alter the structure and function of the left ventricle. This study presents a unified finite element framework that systematically evaluates the individual and combined contributions of fiber reorientation and baroreflex regulation to left ventricular growth and remodeling, along with the effects of myocardial material property changes associated with the acute and chronic phases of mitral regurgitation. The growth model that included both fiber reorientation and baroreflex most accurately reproduced clinical measurements of ventricular geometry (including chamber sphericity), myocardial mass, and pressure-volume loops. These findings highlight the critical role of integrating concurrent physiological mechanisms to reliably predict cardiac adaptation and provide new insights into the drivers of remodeling patterns observed in patients.
二尖瓣反流(MR)触发复杂的心脏重塑反应,改变左心室(LV)的结构和功能。虽然已经开发了几种模型来预测MR下的心肌生长,但它们往往忽略了影响左室扩张模式和严重程度的关键并发适应机制。本研究提出了一个统一的有限元框架,以系统地评估纤维重定向(FR)和压力反射调节对左室生长和重塑的单独和综合贡献,以及与MR急性和慢性期相关的心肌物质特性变化的影响。包括FR和压反射的生长模型最准确地再现了左室几何形状、心肌质量和压力-容积循环的临床测量结果。排除FR或气压反射都会导致心肌生长的低估和不太真实的左室形状。重要的是,FR对于捕获MR中观察到的增大的腔室球形度至关重要,而气压反射显著影响了扩张和压力补偿的程度。心肌物质特性的相位依赖性变化进一步调节了重构模式,捕捉到了急性和慢性疾病阶段的明显特征。这些发现强调了整合同步生理机制在MR中可靠预测心脏适应的关键作用,并为患者观察到的重塑模式的驱动因素提供了新的见解。这种全面的方法为评估针对心脏适应不同方面的治疗提供了一个有价值的框架。意义声明:二尖瓣反流触发重构反应,改变左心室的结构和功能。本研究提出了一个统一的有限元框架,系统地评估了纤维重定向和压力反射调节对左心室生长和重构的单独和综合贡献,以及与二尖瓣反流急性和慢性期相关的心肌物质特性变化的影响。包括纤维重定向和压力反射的生长模型最准确地再现了心室几何形状(包括室球度)、心肌质量和压力-容积循环的临床测量。这些发现强调了整合并发生理机制在可靠预测心脏适应方面的关键作用,并为患者观察到的重塑模式的驱动因素提供了新的见解。
{"title":"A unified finite element framework for cardiac growth and remodeling in mitral regurgitation incorporating fiber reorientation and baroreflex","authors":"Mohammad Mehri ,&nbsp;Jonathan F. Wenk","doi":"10.1016/j.actbio.2025.12.012","DOIUrl":"10.1016/j.actbio.2025.12.012","url":null,"abstract":"<div><div>Mitral regurgitation (MR) triggers complex cardiac remodeling responses that alter the structure and function of the left ventricle (LV). While several models have been developed to predict myocardial growth in MR, they often neglect key concurrent adaptive mechanisms that influence both the pattern and severity of LV dilation. This study presents a unified finite element framework to systematically evaluate the individual and combined contributions of fiber reorientation (FR) and baroreflex regulation to LV growth and remodeling, along with the effects of myocardial material property changes associated with the acute and chronic phases of MR. A healthy baseline model and multiple MR models were simulated, each incorporating different combinations of these mechanisms. The growth model that included both FR and baroreflex most accurately reproduced clinical measurements of LV geometry, myocardial mass, and pressure-volume loops. Excluding either FR or baroreflex consistently led to underestimation of myocardial growth and less realistic LV shapes. Importantly, FR was essential for capturing the increased chamber sphericity observed in MR, while baroreflex significantly influenced the extent of dilation and pressure compensation. Phase-dependent changes in myocardial material properties further modulated remodeling patterns, capturing distinct features of acute and chronic disease stages. These findings highlight the critical role of integrating concurrent physiological mechanisms to reliably predict cardiac adaptation in MR and provide new insights into the drivers of remodeling patterns observed in patients. This comprehensive approach offers a valuable framework for evaluating therapies that target distinct aspects of cardiac adaptation.</div></div><div><h3>Statement of Significance</h3><div>Mitral regurgitation triggers remodeling responses that alter the structure and function of the left ventricle. This study presents a unified finite element framework that systematically evaluates the individual and combined contributions of fiber reorientation and baroreflex regulation to left ventricular growth and remodeling, along with the effects of myocardial material property changes associated with the acute and chronic phases of mitral regurgitation. The growth model that included both fiber reorientation and baroreflex most accurately reproduced clinical measurements of ventricular geometry (including chamber sphericity), myocardial mass, and pressure-volume loops. These findings highlight the critical role of integrating concurrent physiological mechanisms to reliably predict cardiac adaptation and provide new insights into the drivers of remodeling patterns observed in patients.</div></div>","PeriodicalId":237,"journal":{"name":"Acta Biomaterialia","volume":"210 ","pages":"Pages 110-120"},"PeriodicalIF":9.6,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145702810","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial intelligence-assisted multiscale lung modeling to predict alveolar septal wall stress 人工智能辅助的多尺度肺模型预测肺泡间隔壁应力。
IF 9.6 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2026-01-01 DOI: 10.1016/j.actbio.2025.11.030
Sunder Neelakantan , Mostafa K. Ismail , Nikhil Kadivar , Elizabeth McGinn , Luis Loza , Kyle J. Myers , Bradford J. Smith , Rahim Rizi , George Karniadakis , Reza Avazmohammadi
Injuries to the lung parenchyma, such as radiation-induced lung injury (RILI), can lead to heterogeneous ventilation and reduced lung function. The biomechanical drivers behind the onset and progression of such lung injuries are poorly understood. In this study, we developed a method based on tissue mechanical modeling and machine learning to estimate in-vivo alveolar septal wall stress, to understand the effect of parenchymal biomechanics on the onset and progression of lung injuries. Representative tissue elements (RTEs) of the lung parenchyma were reconstructed from X-ray microtomography imaging. A generative adversarial network (GAN) model was used to create synthetic RTEs to enhance the training data for an artificial neural network (ANN). Feature analysis indicated that the GAN model generated synthetic RTEs with features similar to those of the segmented RTEs. Finite element simulations were performed on both the segmented and synthetic RTEs and used to train the ANN. Stretch and geometric features served as inputs, and RTE stresses were the outputs. The ANN’s testing accuracy was 61.6% before and 84.0% after including the synthetic RTEs. We used the ANN to investigate the evolution of stress in a rodent model of RILI. Reduced stress was observed in the lung tissue at 3-month post-radiation, indicating pneumonitis, followed by elevated stress at 5-month post-radiation, suggesting regional fibrosis. Further, stress heterogeneity at the 5-month timepoint indicated the presence of volutrauma. Overall, these results suggest that regional biomechanical markers can be used for early diagnosis and assessment of subclinical lung injuries that existing global measures cannot detect.
Statement of Significance
Injuries to the lung parenchymal tissue, such as radiation-induced lung injury (RILI), can lead to heterogeneous ventilation and reduced lung function. The drivers behind the onset and progression of such lung injuries are poorly understood. In this study, we developed a method to estimate alveolar septal wall stress (SWS) in vivo, through a combination of tissue mechanics, multiscale modeling, and machine learning (ML), to understand the effect of parenchymal biomechanics on the onset and progression of lung injuries. We applied the method to investigate a rodent model of RILI. The ML-based method could capture the pneumonitis and fibrosis behavior associated with early- and late-stage parenchymal remodeling post radiation, respectively. We expect that regional stresses in the lung parenchyma will provide key insights, including those obfuscated from global measures, into the onset and progression of lung injuries.
肺实质损伤,如辐射性肺损伤(RILI),可导致不均匀通气和肺功能降低。这种肺损伤发生和发展背后的生物力学驱动因素尚不清楚。在这项研究中,我们开发了一种基于组织力学建模和机器学习的方法来估计体内肺泡间隔壁应力,以了解实质生物力学对肺损伤发生和进展的影响。通过x射线显微断层成像重建肺实质的代表性组织元素(rte)。采用生成式对抗网络(GAN)模型来生成合成rte,以增强人工神经网络(ANN)的训练数据。特征分析表明,GAN模型生成的合成rte具有与分割后的rte相似的特征。分别对分段rte和合成rte进行了有限元仿真,并用于训练人工神经网络。拉伸和几何特征作为输入,RTE应力作为输出。人工神经网络在加入合成rte前的测试准确率为61.6%,加入合成rte后的测试准确率为84.0%。我们使用人工神经网络来研究RILI啮齿动物模型的应激演变。放疗后3个月肺组织应激降低,提示肺炎,放疗后5个月应激升高,提示区域性纤维化。此外,5个月时间点的应力异质性表明存在体积创伤。总的来说,这些结果表明,区域生物力学标志物可以用于亚临床肺损伤的早期诊断和评估,而现有的全球措施无法检测到。肺实质组织损伤,如辐射性肺损伤(RILI)可导致非均匀通气和肺功能降低。这种肺损伤发生和发展背后的驱动因素尚不清楚。在这项研究中,我们通过组织力学、多尺度建模和机器学习相结合,开发了一种估算肺泡间隔壁应力(SWS)的方法,以了解实质生物力学对肺损伤发生和进展的影响。我们将该方法应用于啮齿类动物RILI模型的研究。基于ml的方法可以分别捕获与放射后早期和晚期实质重构相关的肺炎和纤维化行为。我们期望肺实质的区域应力将为肺损伤的发生和进展提供关键的见解,包括那些从全球测量中混淆的见解。
{"title":"Artificial intelligence-assisted multiscale lung modeling to predict alveolar septal wall stress","authors":"Sunder Neelakantan ,&nbsp;Mostafa K. Ismail ,&nbsp;Nikhil Kadivar ,&nbsp;Elizabeth McGinn ,&nbsp;Luis Loza ,&nbsp;Kyle J. Myers ,&nbsp;Bradford J. Smith ,&nbsp;Rahim Rizi ,&nbsp;George Karniadakis ,&nbsp;Reza Avazmohammadi","doi":"10.1016/j.actbio.2025.11.030","DOIUrl":"10.1016/j.actbio.2025.11.030","url":null,"abstract":"<div><div>Injuries to the lung parenchyma, such as radiation-induced lung injury (RILI), can lead to heterogeneous ventilation and reduced lung function. The biomechanical drivers behind the onset and progression of such lung injuries are poorly understood. In this study, we developed a method based on tissue mechanical modeling and machine learning to estimate in-vivo alveolar septal wall stress, to understand the effect of parenchymal biomechanics on the onset and progression of lung injuries. Representative tissue elements (RTEs) of the lung parenchyma were reconstructed from X-ray microtomography imaging. A generative adversarial network (GAN) model was used to create synthetic RTEs to enhance the training data for an artificial neural network (ANN). Feature analysis indicated that the GAN model generated synthetic RTEs with features similar to those of the segmented RTEs. Finite element simulations were performed on both the segmented and synthetic RTEs and used to train the ANN. Stretch and geometric features served as inputs, and RTE stresses were the outputs. The ANN’s testing accuracy was 61.6% before and 84.0% after including the synthetic RTEs. We used the ANN to investigate the evolution of stress in a rodent model of RILI. Reduced stress was observed in the lung tissue at 3-month post-radiation, indicating pneumonitis, followed by elevated stress at 5-month post-radiation, suggesting regional fibrosis. Further, stress heterogeneity at the 5-month timepoint indicated the presence of volutrauma. Overall, these results suggest that regional biomechanical markers can be used for early diagnosis and assessment of subclinical lung injuries that existing global measures cannot detect.</div><div><em>Statement of Significance</em></div><div>Injuries to the lung parenchymal tissue, such as radiation-induced lung injury (RILI), can lead to heterogeneous ventilation and reduced lung function. The drivers behind the onset and progression of such lung injuries are poorly understood. In this study, we developed a method to estimate alveolar septal wall stress (SWS) in vivo, through a combination of tissue mechanics, multiscale modeling, and machine learning (ML), to understand the effect of parenchymal biomechanics on the onset and progression of lung injuries. We applied the method to investigate a rodent model of RILI. The ML-based method could capture the pneumonitis and fibrosis behavior associated with early- and late-stage parenchymal remodeling post radiation, respectively. We expect that regional stresses in the lung parenchyma will provide key insights, including those obfuscated from global measures, into the onset and progression of lung injuries.</div></div>","PeriodicalId":237,"journal":{"name":"Acta Biomaterialia","volume":"210 ","pages":"Pages 121-132"},"PeriodicalIF":9.6,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145643641","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aquatic collagen for tissue repair: process–structure–function design from sustainable sourcing to clinical translation 用于组织修复的水生胶原蛋白:从可持续来源到临床转化的过程-结构-功能设计。
IF 9.6 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2026-01-01 DOI: 10.1016/j.actbio.2025.12.003
Xin Xiong , Shuai Wang , Yuqing Tan , Sutee Wangtueai , Hui Hong , Yongkang Luo
Aquatic-derived collagen has emerged as a promising biomaterial for tissue engineering and biotechnology due to its superior biocompatibility, low immunogenicity, and structural compatibility with human ECM. This review synthesizes current progress on collagen from aquatic sources, highlighting sustainable extraction techniques such as ultrasonication and enzymatic hydrolysis. Compared to mammalian collagen, aquatic-derived collagen offers unique benefits, including a reduced zoonotic disease risk and increased environmental sustainability. We explore advanced fabrication techniques, including 3D printing and electrospinning, that utilize aquatic-derived collagen for a range of biomedical applications, from wound healing and bone regeneration to retinal tissue repair. By assessing both current applications and future directions, including the development of personalized scaffolds and intelligent biomaterials, we demonstrate the potential of aquatic-derived collagen to advance the field of tissue engineering and regenerative medicine, providing sustainable solutions for next-generation therapeutic interventions.

Statement of significance

This review links sustainability with translation in collagen biomaterials by consolidating evidence on aquatic collagen derived from fishery and aquaculture by-products. We critically compare green extraction routes and biofabrication strategies and map how they affect collagen structure, fibrillogenesis, mechanics, immunogenic risk and cell signaling relevant to regeneration. By benchmarking aquatic versus mammalian collagens and distilling design rules for printable, mineralized and antimicrobial hydrogels/bioinks, we show how waste valorization can reduce environmental burden while meeting functional demands in wound, musculoskeletal, ocular and cardiac repair. We also identify standardization gaps—including source variability, purity/endotoxin specifications and batch analytics—and propose practical reporting checklists to improve reproducibility and regulatory readiness. This review provides a mechanism-anchored, sustainability-first roadmap for translating discarded marine biomass into clinically relevant collagen materials.
水源性胶原因其优异的生物相容性、低免疫原性和与人ECM的结构相容性而成为组织工程和生物技术的一种有前景的生物材料。本文综述了水产胶原蛋白的最新研究进展,重点介绍了超声法和酶解法等可持续提取技术。与哺乳动物胶原蛋白相比,水生胶原蛋白具有独特的优势,包括降低人畜共患病风险和提高环境可持续性。我们探索先进的制造技术,包括3D打印和静电纺丝,利用水生胶原蛋白进行一系列生物医学应用,从伤口愈合和骨再生到视网膜组织修复。通过评估目前的应用和未来的方向,包括个性化支架和智能生物材料的发展,我们展示了水生胶原蛋白在推进组织工程和再生医学领域的潜力,为下一代治疗干预提供了可持续的解决方案。意义声明:本综述通过巩固来自渔业和水产养殖副产品的水生胶原蛋白的证据,将可持续性与胶原蛋白生物材料的转化联系起来。我们批判性地比较了绿色提取路线和生物制造策略,并绘制了它们如何影响胶原结构、纤维形成、力学、免疫原性风险和与再生相关的细胞信号。通过对水生动物和哺乳动物胶原蛋白进行基准测试,并对可打印、矿化和抗菌水凝胶/生物墨水的设计规则进行提取,我们展示了废物价值化如何减轻环境负担,同时满足伤口、肌肉骨骼、眼睛和心脏修复的功能需求。我们还确定标准化差距-包括来源可变性,纯度/内毒素规格和批分析-并提出实用的报告清单,以提高可重复性和监管准备。这篇综述为将废弃的海洋生物质转化为临床相关的胶原蛋白材料提供了一个机制锚定的、可持续优先的路线图。
{"title":"Aquatic collagen for tissue repair: process–structure–function design from sustainable sourcing to clinical translation","authors":"Xin Xiong ,&nbsp;Shuai Wang ,&nbsp;Yuqing Tan ,&nbsp;Sutee Wangtueai ,&nbsp;Hui Hong ,&nbsp;Yongkang Luo","doi":"10.1016/j.actbio.2025.12.003","DOIUrl":"10.1016/j.actbio.2025.12.003","url":null,"abstract":"<div><div>Aquatic-derived collagen has emerged as a promising biomaterial for tissue engineering and biotechnology due to its superior biocompatibility, low immunogenicity, and structural compatibility with human ECM. This review synthesizes current progress on collagen from aquatic sources, highlighting sustainable extraction techniques such as ultrasonication and enzymatic hydrolysis. Compared to mammalian collagen, aquatic-derived collagen offers unique benefits, including a reduced zoonotic disease risk and increased environmental sustainability. We explore advanced fabrication techniques, including 3D printing and electrospinning, that utilize aquatic-derived collagen for a range of biomedical applications, from wound healing and bone regeneration to retinal tissue repair. By assessing both current applications and future directions, including the development of personalized scaffolds and intelligent biomaterials, we demonstrate the potential of aquatic-derived collagen to advance the field of tissue engineering and regenerative medicine, providing sustainable solutions for next-generation therapeutic interventions.</div></div><div><h3>Statement of significance</h3><div>This review links sustainability with translation in collagen biomaterials by consolidating evidence on aquatic collagen derived from fishery and aquaculture by-products. We critically compare green extraction routes and biofabrication strategies and map how they affect collagen structure, fibrillogenesis, mechanics, immunogenic risk and cell signaling relevant to regeneration. By benchmarking aquatic versus mammalian collagens and distilling design rules for printable, mineralized and antimicrobial hydrogels/bioinks, we show how waste valorization can reduce environmental burden while meeting functional demands in wound, musculoskeletal, ocular and cardiac repair. We also identify standardization gaps—including source variability, purity/endotoxin specifications and batch analytics—and propose practical reporting checklists to improve reproducibility and regulatory readiness. This review provides a mechanism-anchored, sustainability-first roadmap for translating discarded marine biomass into clinically relevant collagen materials.</div></div>","PeriodicalId":237,"journal":{"name":"Acta Biomaterialia","volume":"210 ","pages":"Pages 375-397"},"PeriodicalIF":9.6,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145679603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trojan horse natural killer cells enhance targeted drug delivery and boost memory T cell-mediated immune responses in triple-negative breast cancer 特洛伊木马自然杀伤细胞在三阴性乳腺癌中增强靶向药物递送和增强记忆T细胞介导的免疫反应。
IF 9.6 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2026-01-01 DOI: 10.1016/j.actbio.2025.12.009
Liya Wu , Hua Yao , Yubo Wang , Haiou Liu , Huiying Lv , Dan Jiao , Jinlan Jiang
Natural killer (NK) cell-based cancer therapy is a key innovation in immunotherapy. However, current research on drug delivery systems (DDSs) mediated by NK "dead cells" remains limited. Accordingly, we developed an innovative method to obtain dead NK cells as drug carriers using rapid vitrification freezing and slow-programmed thawing. Freeze-thawed NK cells (FTKs) showed enhanced tumor-targeting ability by upregulating the expression of C-X-C motif chemokine receptor 3 and integrin beta 2. Therefore, FTKs function as Trojan horse-like carriers, enabling efficient delivery of toxic chemotherapeutic agents. In addition, FTKs were also found to stimulate the maturation of dendritic cells (DCs) via the release of danger-associated molecular patterns. In conjunction with chemotherapy, this strategy can synergistically leverage the immunomodulatory properties of chemotherapeutic drugs to increase immunogenic cell death, mitigate immunosuppression within the tumor microenvironment, and slow the progression of triple-negative breast cancer (TNBC). Using a metastatic TNBC mouse model, this strategy enhanced the immunological effect of a programmed cell death protein 1 inhibitor by re-invigorating cytotoxic T lymphocytes and promoting the reacquisition of memory T-cell responses. Hence, we propose an NK “dead cell”-based enhanced target delivery system that can be rapidly manufactured for clinical use, thus providing insights into innovative immunotherapy drug delivery strategies.

Statement of significance

Triple-negative breast cancer is a highly aggressive subtype of breast cancer, for which chemotherapy is the primary treatment modality. However, conventional chemotherapy is often limited by insufficient target specificity, leading to systemic toxicity. In this study, we developed a drug delivery platform based on natural killer (NK) cells. By processing cells via rapid vitrification freezing and slow-programmed thawing, we obtained freeze–thawed NK cells (FTKs) characterized by an intact membrane architecture and enhanced tumor-targeting capacity. In addition, FTKs were found to promote dendritic cell maturation and had a high drug-loading capacity. In conjunction with chemotherapy, this strategy enhanced the immunological effect of a programmed cell death protein 1 inhibitor by re-invigorating cytotoxic T lymphocytes and promoting the reacquisition of memory T-cell responses.
基于NK细胞的肿瘤治疗是免疫治疗领域的一项重要创新。然而,目前对NK“死细胞”介导的药物传递系统(dds)的研究仍然有限。因此,我们开发了一种创新的方法来获得死亡NK细胞作为药物载体,使用快速玻璃化冷冻和缓慢程序解冻。冻融NK细胞(FTKs)通过上调C-X-C基序趋化因子受体3和整合素β 2的表达,显示出增强的肿瘤靶向能力。因此,ftk作为特洛伊木马一样的载体,能够有效地递送有毒的化疗药物。此外,ftk还被发现通过释放危险相关的分子模式来刺激树突状细胞(DCs)的成熟。结合化疗,该策略可以协同利用化疗药物的免疫调节特性来增加免疫原性细胞死亡,减轻肿瘤微环境中的免疫抑制,并减缓三阴性乳腺癌(TNBC)的进展。在转移性TNBC小鼠模型中,该策略通过重新激活细胞毒性T淋巴细胞和促进记忆性T细胞反应的重新获得,增强了程序性细胞死亡蛋白1抑制剂的免疫效果。因此,我们提出了一种基于NK“死细胞”的增强靶标递送系统,可以快速制造用于临床使用,从而为创新免疫治疗药物递送策略提供见解。意义声明:三阴性乳腺癌是一种高度侵袭性的乳腺癌亚型,化疗是其主要治疗方式。然而,传统的化疗往往受到靶点特异性不足的限制,导致全身毒性。在这项研究中,我们开发了一个基于自然杀伤(NK)细胞的药物传递平台。通过快速玻璃化冷冻和缓慢程序解冻处理细胞,我们获得了具有完整膜结构和增强肿瘤靶向能力的冻融NK细胞(FTKs)。此外,FTKs被发现可以促进树突细胞成熟,并且具有很高的载药能力。结合化疗,该策略通过重新激活细胞毒性T淋巴细胞和促进记忆T细胞反应的重新获得,增强了程序性细胞死亡蛋白1抑制剂的免疫效果。
{"title":"Trojan horse natural killer cells enhance targeted drug delivery and boost memory T cell-mediated immune responses in triple-negative breast cancer","authors":"Liya Wu ,&nbsp;Hua Yao ,&nbsp;Yubo Wang ,&nbsp;Haiou Liu ,&nbsp;Huiying Lv ,&nbsp;Dan Jiao ,&nbsp;Jinlan Jiang","doi":"10.1016/j.actbio.2025.12.009","DOIUrl":"10.1016/j.actbio.2025.12.009","url":null,"abstract":"<div><div>Natural killer (NK) cell-based cancer therapy is a key innovation in immunotherapy. However, current research on drug delivery systems (DDSs) mediated by NK \"dead cells\" remains limited. Accordingly, we developed an innovative method to obtain dead NK cells as drug carriers using rapid vitrification freezing and slow-programmed thawing. Freeze-thawed NK cells (FTKs) showed enhanced tumor-targeting ability by upregulating the expression of C-X-C motif chemokine receptor 3 and integrin beta 2. Therefore, FTKs function as Trojan horse-like carriers, enabling efficient delivery of toxic chemotherapeutic agents. In addition, FTKs were also found to stimulate the maturation of dendritic cells (DCs) via the release of danger-associated molecular patterns. In conjunction with chemotherapy, this strategy can synergistically leverage the immunomodulatory properties of chemotherapeutic drugs to increase immunogenic cell death, mitigate immunosuppression within the tumor microenvironment, and slow the progression of triple-negative breast cancer (TNBC). Using a metastatic TNBC mouse model, this strategy enhanced the immunological effect of a programmed cell death protein 1 inhibitor by re-invigorating cytotoxic T lymphocytes and promoting the reacquisition of memory T-cell responses. Hence, we propose an NK “dead cell”-based enhanced target delivery system that can be rapidly manufactured for clinical use, thus providing insights into innovative immunotherapy drug delivery strategies.</div></div><div><h3>Statement of significance</h3><div>Triple-negative breast cancer is a highly aggressive subtype of breast cancer, for which chemotherapy is the primary treatment modality. However, conventional chemotherapy is often limited by insufficient target specificity, leading to systemic toxicity. In this study, we developed a drug delivery platform based on natural killer (NK) cells. By processing cells via rapid vitrification freezing and slow-programmed thawing, we obtained freeze–thawed NK cells (FTKs) characterized by an intact membrane architecture and enhanced tumor-targeting capacity. In addition, FTKs were found to promote dendritic cell maturation and had a high drug-loading capacity. In conjunction with chemotherapy, this strategy enhanced the immunological effect of a programmed cell death protein 1 inhibitor by re-invigorating cytotoxic T lymphocytes and promoting the reacquisition of memory T-cell responses.</div></div>","PeriodicalId":237,"journal":{"name":"Acta Biomaterialia","volume":"210 ","pages":"Pages 481-498"},"PeriodicalIF":9.6,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145696528","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Regulation of immune factor secretion by nanofiber microstructures 纳米纤维微结构对免疫因子分泌的调节。
IF 9.6 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2026-01-01 DOI: 10.1016/j.actbio.2025.12.017
Yulian Zheng , Maoping Li , Yang Cao , Yiting Lei , Liang Zhang , Zhiling Luo , E Yang , Yang Gao , Xiao Shen , Wei Huang , Hengshu Zhang , Wenguo Cui , Lu Chen
The imbalance of immune factor secretion plays a critical role in the dysregulation of immune homeostasis, contributing to chronic inflammation and impaired tissue regeneration. Nanofiber microstructures have emerged as promising biomaterials in tissue regeneration due to their ability to modulate immune cell behavior. However, the mechanisms by which nanofiber microstructures regulate immune factor secretion remain poorly understood. In this study, we fabricated three types of nanofibers with varying degrees of alignment microstructures and investigated their effects on immune factor secretion of immune cells. In vitro analyses revealed that highly aligned nanofibers significantly enhanced the secretion of anti-inflammatory factors such as TGF-β1 and IL-10, while suppressing pro-inflammatory factors including TNF-α and IL-6. These effects were mediated through the modulation of immune cell adhesion receptors and mechanotransduction pathways. Furthermore, in vivo experiments demonstrated that highly aligned nanofibers optimized the immune microenvironment at wound sites, promoting angiogenesis and accelerating tissue regeneration. This study introduces an alternative perspective on biomaterial-based immune regulation, highlighting the critical role of nanofiber microstructures in directing immune cell functions. These findings provide a foundation for the rational design of biomaterials with tailored microstructures to achieve precise immune modulation, offering strategies for enhancing wound healing and advancing regenerative medicine.

Statement of significance

Dysregulated immune factor secretion is a major contributor to chronic inflammation and impaired tissue regeneration. Current strategies that rely on exogenous cytokines are constrained by short half-lives and uncontrollable release kinetics. Given that immune cells are the primary source of these factors, direct modulation of their local secretory profiles offers a more stable and sustained alternative. Here, we introduce a nanofiber microstructure–based approach to program immune cell secretory behavior. We demonstrate, for the first time, that highly aligned nanofibers remodel the immune secretome via the integrin α10β1/PI3K/AKT signaling pathway, thereby reestablishing a pro-regenerative immune microenvironment and enhancing tissue repair. This study establishes a new paradigm in which biomaterials precisely reprogram immune secretory function, laying the foundation for programmable immunoregulatory materials with strong translational potential.
免疫因子分泌失衡在免疫稳态失调中起着至关重要的作用,导致慢性炎症和组织再生受损。纳米纤维微结构由于其调节免疫细胞行为的能力而成为组织再生中有前途的生物材料。然而,纳米纤维微结构调节免疫因子分泌的机制仍然知之甚少。在本研究中,我们制备了三种不同排列程度的纳米纤维,并研究了它们对免疫细胞分泌免疫因子的影响。体外分析显示,高度排列的纳米纤维显著增强TGF-β1和IL-10等抗炎因子的分泌,同时抑制TNF-α和IL-6等促炎因子。这些作用是通过调节免疫细胞粘附受体和机械转导途径介导的。此外,体内实验表明,高度排列的纳米纤维优化了伤口部位的免疫微环境,促进血管生成和加速组织再生。本研究介绍了基于生物材料的免疫调节的另一种观点,强调了纳米纤维微结构在指导免疫细胞功能中的关键作用。这些发现为合理设计具有定制微结构的生物材料以实现精确的免疫调节提供了基础,为促进伤口愈合和推进再生医学提供了策略。意义声明:免疫因子分泌失调是慢性炎症和组织再生受损的主要原因。目前依赖外源性细胞因子的策略受到半衰期短和不可控释放动力学的限制。鉴于免疫细胞是这些因子的主要来源,直接调节其局部分泌谱提供了更稳定和持续的替代方案。在这里,我们介绍了一种基于纳米纤维微结构的方法来编程免疫细胞的分泌行为。我们首次证明,高度排列的纳米纤维通过整合素α10β1/PI3K/AKT信号通路重塑免疫分泌组,从而重建促再生免疫微环境并增强组织修复。本研究建立了生物材料精确重编程免疫分泌功能的新范式,为具有强大翻译潜力的可编程免疫调节材料奠定了基础。
{"title":"Regulation of immune factor secretion by nanofiber microstructures","authors":"Yulian Zheng ,&nbsp;Maoping Li ,&nbsp;Yang Cao ,&nbsp;Yiting Lei ,&nbsp;Liang Zhang ,&nbsp;Zhiling Luo ,&nbsp;E Yang ,&nbsp;Yang Gao ,&nbsp;Xiao Shen ,&nbsp;Wei Huang ,&nbsp;Hengshu Zhang ,&nbsp;Wenguo Cui ,&nbsp;Lu Chen","doi":"10.1016/j.actbio.2025.12.017","DOIUrl":"10.1016/j.actbio.2025.12.017","url":null,"abstract":"<div><div>The imbalance of immune factor secretion plays a critical role in the dysregulation of immune homeostasis, contributing to chronic inflammation and impaired tissue regeneration. Nanofiber microstructures have emerged as promising biomaterials in tissue regeneration due to their ability to modulate immune cell behavior. However, the mechanisms by which nanofiber microstructures regulate immune factor secretion remain poorly understood. In this study, we fabricated three types of nanofibers with varying degrees of alignment microstructures and investigated their effects on immune factor secretion of immune cells. <em>In vitro</em> analyses revealed that highly aligned nanofibers significantly enhanced the secretion of anti-inflammatory factors such as TGF-β1 and IL-10, while suppressing pro-inflammatory factors including TNF-α and IL-6. These effects were mediated through the modulation of immune cell adhesion receptors and mechanotransduction pathways. Furthermore, <em>in vivo</em> experiments demonstrated that highly aligned nanofibers optimized the immune microenvironment at wound sites, promoting angiogenesis and accelerating tissue regeneration. This study introduces an alternative perspective on biomaterial-based immune regulation, highlighting the critical role of nanofiber microstructures in directing immune cell functions. These findings provide a foundation for the rational design of biomaterials with tailored microstructures to achieve precise immune modulation, offering strategies for enhancing wound healing and advancing regenerative medicine.</div></div><div><h3>Statement of significance</h3><div>Dysregulated immune factor secretion is a major contributor to chronic inflammation and impaired tissue regeneration. Current strategies that rely on exogenous cytokines are constrained by short half-lives and uncontrollable release kinetics. Given that immune cells are the primary source of these factors, direct modulation of their local secretory profiles offers a more stable and sustained alternative. Here, we introduce a nanofiber microstructure–based approach to program immune cell secretory behavior. We demonstrate, for the first time, that highly aligned nanofibers remodel the immune secretome via the integrin α10β1/PI3K/AKT signaling pathway, thereby reestablishing a pro-regenerative immune microenvironment and enhancing tissue repair. This study establishes a new paradigm in which biomaterials precisely reprogram immune secretory function, laying the foundation for programmable immunoregulatory materials with strong translational potential.</div></div>","PeriodicalId":237,"journal":{"name":"Acta Biomaterialia","volume":"210 ","pages":"Pages 343-354"},"PeriodicalIF":9.6,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145746172","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Computationally identified peptides immobilized to hydrogel delivery vehicles enable affinity-controlled release of proteins 计算鉴定肽固定化到水凝胶运载工具使亲和控制的蛋白质释放。
IF 9.6 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2026-01-01 DOI: 10.1016/j.actbio.2025.12.034
Yuan Yao , Celestine Hong , Carter J. Teal , Noor E. Bahsoun , Sophia P. Lu , Ian Fernandes , Gordon Keller , Molly Shoichet
The administration of therapeutic proteins, such as growth factors, can be accomplished through affinity-based release systems, yet identifying suitable binding partners that achieve high protein loading and desirable release kinetics remains a significant challenge. In this work, we used a computationally guided approach to identify binding peptides for therapeutic proteins, significantly increasing the loading capacity of the functionalized hydrogel delivery platform. Using crystal structure data from the Protein Data Bank and Rosetta-based rational design, we extracted a 10 amino acid peptide segment from the heavy chain of bevacizumab to modulate the release of vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF). Biolayer interferometry confirmed moderate binding affinity to VEGF (KD 10−5 M) and higher affinity for PDGF (KD 10−7 M). Mutational analysis revealed that aromatic residues were essential for binding. When covalently immobilized to a hyaluronan-methylcellulose hydrogel, the peptide enabled prolonged and sequential release of VEGF and PDGF. Computational modeling of the release kinetics using finite element analysis agreed with experimental data, validating the model and guiding the design of the delivery system. Importantly, the released proteins remained bioactive as demonstrated by cell growth and angiogenesis tube formation assays. This study demonstrates a simple and effective approach to achieve controlled and sequential release of therapeutic growth factors.

Statement of significance

Proteins are promising therapeutics for multiple diseases; however, their delivery remains challenging due to the use of generic strategies, which often degrade the proteins. We used computational tools to identify specific binders for two growth factors (VEGF and PDGF), and then demonstrated the utility of these binders to control the release of bioactive proteins for a sustained period from a novel hydrogel. We achieved sequential release of VEGF followed by PDGF, which is important in vessel formation. This new system of identifying protein binding partners is broadly applicable and shown herein to be useful to control the release of two specific proteins. This combination of theoretical and experimental approaches is of broad interest to biomaterial researchers.
治疗性蛋白(如生长因子)的给药可以通过基于亲和力的释放系统来完成,但确定合适的结合伙伴,实现高蛋白质负载和理想的释放动力学仍然是一个重大挑战。在这项工作中,我们使用了一种计算指导的方法来识别治疗蛋白的结合肽,显著提高了功能化水凝胶递送平台的负载能力。利用蛋白质数据库的晶体结构数据和基于rosetta的合理设计,我们从贝伐单抗的重链中提取了一个10个氨基酸的肽段,以调节血管内皮生长因子(VEGF)和血小板衍生生长因子(PDGF)的释放。生物层干涉测定证实了对VEGF的中等结合亲和力(KD 10-5 M)和对PDGF的较高亲和力(KD 10-7 M)。突变分析显示芳香残基是结合所必需的。当共价固定在透明质酸-甲基纤维素水凝胶上时,肽能够延长和顺序释放VEGF和PDGF。基于有限元分析的释放动力学计算模型与实验数据一致,验证了模型的有效性,并指导了给药系统的设计。重要的是,释放的蛋白质在细胞生长和血管生成管形成实验中仍然具有生物活性。本研究展示了一种简单有效的方法来实现治疗性生长因子的控制和顺序释放。意义声明:蛋白质是多种疾病的有希望的治疗方法;然而,由于使用了通常会降解蛋白质的通用策略,它们的递送仍然具有挑战性。我们使用计算工具确定了两种生长因子(VEGF和PDGF)的特异性结合物,然后证明了这些结合物在一种新型水凝胶中持续一段时间控制生物活性蛋白释放的效用。我们实现了连续释放VEGF和PDGF,这在血管形成中很重要。这种识别蛋白质结合伙伴的新系统是广泛适用的,并在此显示对控制两种特定蛋白质的释放有用。这种理论和实验方法的结合引起了生物材料研究人员的广泛兴趣。
{"title":"Computationally identified peptides immobilized to hydrogel delivery vehicles enable affinity-controlled release of proteins","authors":"Yuan Yao ,&nbsp;Celestine Hong ,&nbsp;Carter J. Teal ,&nbsp;Noor E. Bahsoun ,&nbsp;Sophia P. Lu ,&nbsp;Ian Fernandes ,&nbsp;Gordon Keller ,&nbsp;Molly Shoichet","doi":"10.1016/j.actbio.2025.12.034","DOIUrl":"10.1016/j.actbio.2025.12.034","url":null,"abstract":"<div><div>The administration of therapeutic proteins, such as growth factors, can be accomplished through affinity-based release systems, yet identifying suitable binding partners that achieve high protein loading and desirable release kinetics remains a significant challenge. In this work, we used a computationally guided approach to identify binding peptides for therapeutic proteins, significantly increasing the loading capacity of the functionalized hydrogel delivery platform. Using crystal structure data from the Protein Data Bank and Rosetta-based rational design, we extracted a 10 amino acid peptide segment from the heavy chain of bevacizumab to modulate the release of vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF). Biolayer interferometry confirmed moderate binding affinity to VEGF (K<sub>D</sub> 10<sup>−5</sup> M) and higher affinity for PDGF (K<sub>D</sub> 10<sup>−7</sup> M). Mutational analysis revealed that aromatic residues were essential for binding. When covalently immobilized to a hyaluronan-methylcellulose hydrogel, the peptide enabled prolonged and sequential release of VEGF and PDGF. Computational modeling of the release kinetics using finite element analysis agreed with experimental data, validating the model and guiding the design of the delivery system. Importantly, the released proteins remained bioactive as demonstrated by cell growth and angiogenesis tube formation assays. This study demonstrates a simple and effective approach to achieve controlled and sequential release of therapeutic growth factors.</div></div><div><h3>Statement of significance</h3><div>Proteins are promising therapeutics for multiple diseases; however, their delivery remains challenging due to the use of generic strategies, which often degrade the proteins. We used computational tools to identify specific binders for two growth factors (VEGF and PDGF), and then demonstrated the utility of these binders to control the release of bioactive proteins for a sustained period from a novel hydrogel. We achieved sequential release of VEGF followed by PDGF, which is important in vessel formation. This new system of identifying protein binding partners is broadly applicable and shown herein to be useful to control the release of two specific proteins. This combination of theoretical and experimental approaches is of broad interest to biomaterial researchers.</div></div>","PeriodicalId":237,"journal":{"name":"Acta Biomaterialia","volume":"210 ","pages":"Pages 133-144"},"PeriodicalIF":9.6,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145783845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ROS-sensitive nanocarriers for synergistic X-PDT/chemo/immunotherapy of triple-negative breast cancer and metastasis ros敏感纳米载体协同X-PDT/化疗/免疫治疗三阴性乳腺癌及其转移。
IF 9.6 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2026-01-01 DOI: 10.1016/j.actbio.2025.12.035
Chaorong Wei , Lingke Feng , Jing Liu , Mingxia Xu , Yongsheng Cui , Fengyi Lin , Honglian Yu , Zhanzhan Feng , Hong Zhang , Changyang Gong , Peng Mi
X-ray-induced photodynamic therapy (X-PDT) shows significant promise in tumor treatments due to its unlimited tissue penetration but requires delivering sensitizers to tumors. Here, we engineered photosensitizer verteporfin (VP) and T-lymphokine-activated killer cell-originated protein kinase (TOPK) inhibitor OTS964-encapsulated polymeric nanocarriers (VP/OTS964@NPs) for effective tumor X-PDT, molecule-targeted therapy and inducing robust antitumor immunity for synergistic immunotherapy of low immunogenic breast tumors and their lung metastases when combined with PD-L1 blockade. The VP/OTS964@NPs are monodisperse and can be disassembled to release drugs in response to high reactive oxygen species (ROS) levels in the tumor microenvironment or generated during X-PDT. It can efficiently deliver drugs into the TOPK-high expression breast cancer cells, generate ROS and induce ICD effects. By i.v. injection, VP/OTS964@NPs efficiently accumulated in the breast tumors and effectively eradicated tumors upon X-PDT. Additionally, the VP/OTS964@NPs activated the systemic antitumor immune responses, significantly inhibited the distant breast tumors and the lung metastasis of breast tumors, and enhanced the survival rates in combination with PD-L1 blockade. This study presented a strategy for engineering nanocarriers for synergistic molecular therapy, tumor XDT and immunotherapy.

Statement of significance

X-PDT is a promising therapeutic modality for cancer treatment. However, its clinical application is hindered by the limited availability of suitable sensitizers and their insufficient tumor-targeting capability. This work aims to construct ROS-sensitive nanocarriers co-loaded with the photosensitizer verteporfin and the TOPK inhibitor OTS964 to achieve synergistic X-PDT for triple-negative breast cancer. By further activating antitumor immune responses, this strategy is designed to suppress the distant and metastatic breast tumors. Overall, this work provides both a nanodrug platform and a therapeutic strategy for the treatment of poorly immunogenic solid tumors.
x射线诱导光动力疗法(X-PDT)由于其无限的组织穿透性,在肿瘤治疗中显示出巨大的前景,但需要向肿瘤输送致敏剂。在这里,我们设计了光敏剂维替波芬(VP)和t淋巴因子激活的杀伤细胞源蛋白激酶(TOPK)抑制剂ots964包封的聚合物纳米载体(VP/OTS964@NPs),用于有效的肿瘤X-PDT,分子靶向治疗和诱导强大的抗肿瘤免疫,在联合PD-L1阻断的情况下,用于低免疫原性乳腺肿瘤及其肺转移的协同免疫治疗。VP/OTS964@NPs是单分散的,可以在肿瘤微环境或X-PDT过程中产生的高活性氧(ROS)水平下被分解释放药物。它可以有效地将药物输送到topk高表达的乳腺癌细胞中,产生ROS,诱导ICD效应。通过静脉注射,VP/OTS964@NPs在乳腺肿瘤中有效积累,X-PDT有效根除肿瘤。此外,VP/OTS964@NPs激活全身抗肿瘤免疫应答,显著抑制远处乳腺肿瘤和乳腺肿瘤肺转移,联合PD-L1阻断可提高生存率。本研究提出了一种用于协同分子治疗、肿瘤XDT和免疫治疗的工程纳米载体策略。意义声明:X-PDT是一种很有前途的癌症治疗方式。然而,它的临床应用受到合适的增敏剂有限的可用性和它们的肿瘤靶向能力不足的阻碍。本研究旨在构建ros敏感的纳米载体,与光敏剂维替泊芬和TOPK抑制剂OTS964共载,实现对三阴性乳腺癌的协同X-PDT。通过进一步激活抗肿瘤免疫反应,该策略旨在抑制远处和转移性乳腺肿瘤。总的来说,这项工作为治疗免疫原性差的实体瘤提供了纳米药物平台和治疗策略。
{"title":"ROS-sensitive nanocarriers for synergistic X-PDT/chemo/immunotherapy of triple-negative breast cancer and metastasis","authors":"Chaorong Wei ,&nbsp;Lingke Feng ,&nbsp;Jing Liu ,&nbsp;Mingxia Xu ,&nbsp;Yongsheng Cui ,&nbsp;Fengyi Lin ,&nbsp;Honglian Yu ,&nbsp;Zhanzhan Feng ,&nbsp;Hong Zhang ,&nbsp;Changyang Gong ,&nbsp;Peng Mi","doi":"10.1016/j.actbio.2025.12.035","DOIUrl":"10.1016/j.actbio.2025.12.035","url":null,"abstract":"<div><div>X-ray-induced photodynamic therapy (X-PDT) shows significant promise in tumor treatments due to its unlimited tissue penetration but requires delivering sensitizers to tumors. Here, we engineered photosensitizer verteporfin (VP) and T-lymphokine-activated killer cell-originated protein kinase (TOPK) inhibitor OTS964-encapsulated polymeric nanocarriers (VP/OTS964@NPs) for effective tumor X-PDT, molecule-targeted therapy and inducing robust antitumor immunity for synergistic immunotherapy of low immunogenic breast tumors and their lung metastases when combined with PD-L1 blockade. The VP/OTS964@NPs are monodisperse and can be disassembled to release drugs in response to high reactive oxygen species (ROS) levels in the tumor microenvironment or generated during X-PDT. It can efficiently deliver drugs into the TOPK-high expression breast cancer cells, generate ROS and induce ICD effects. By <em>i.v.</em> injection, VP/OTS964@NPs efficiently accumulated in the breast tumors and effectively eradicated tumors upon X-PDT. Additionally, the VP/OTS964@NPs activated the systemic antitumor immune responses, significantly inhibited the distant breast tumors and the lung metastasis of breast tumors, and enhanced the survival rates in combination with PD-L1 blockade. This study presented a strategy for engineering nanocarriers for synergistic molecular therapy, tumor XDT and immunotherapy.</div></div><div><h3>Statement of significance</h3><div>X-PDT is a promising therapeutic modality for cancer treatment. However, its clinical application is hindered by the limited availability of suitable sensitizers and their insufficient tumor-targeting capability. This work aims to construct ROS-sensitive nanocarriers co-loaded with the photosensitizer verteporfin and the TOPK inhibitor OTS964 to achieve synergistic X-PDT for triple-negative breast cancer. By further activating antitumor immune responses, this strategy is designed to suppress the distant and metastatic breast tumors. Overall, this work provides both a nanodrug platform and a therapeutic strategy for the treatment of poorly immunogenic solid tumors.</div></div>","PeriodicalId":237,"journal":{"name":"Acta Biomaterialia","volume":"210 ","pages":"Pages 441-456"},"PeriodicalIF":9.6,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145783883","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
3D printing of nanoparticle-containing scaffolds for cancer phototherapy, magnetic hyperthermia therapy, and tissue regeneration 用于癌症光疗、磁热疗和组织再生的含纳米颗粒支架的3D打印。
IF 9.6 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2026-01-01 DOI: 10.1016/j.actbio.2025.11.043
Pedro D. Fernandes , Filipa C. Silva , Fernão D. Magalhães , Rúben F. Pereira , Susana G. Santos , Artur M. Pinto
Cancer therapies often leave behind significant tissue damage, creating a critical need for new strategies that can both eradicate tumors and simultaneously regenerate the lost tissues. This review explores the integration of nanoparticle-based treatments with three-dimensional (3D) printing as a promising solution. This synergistic approach uses nanoparticle-mediated cancer therapies, such as photothermal therapy (PTT) and magnetic hyperthermia (MHT), which can selectively destroy tumors while also being able to stimulate angiogenesis and upregulate tissue regenerative pathways. Most research in the field has focused on hard tissue applications, namely bone; however, recent outcomes in soft tissues, such as skin and myocardium, indicate broader translational potential. In addition, immunomodulation and gene therapy within scaffolds are emerging directions that hold great promise but remain underexplored. Current limitations are also discussed, including insufficient vascularization, the need for improved preclinical models, reproducibility challenges, scalability, and regulatory barriers. By consolidating current evidence, identifying underdeveloped areas, and outlining future directions, this review provides a comprehensive and up-to-date assessment of nanoparticle-incorporated 3D-printed scaffolds for synergistic cancer therapy and tissue regeneration (TR). Importantly, this review is the first to systematically integrate PTT, MHT, and TR within a unified 3D-printed scaffold platform, offering a distinct perspective that can guide future developments in the field.

Statement of significance

This review provides the first comprehensive analysis of 3D-printed scaffolds incorporating nanoparticles for combined cancer phototherapy, magnetic hyperthermia therapy, and tissue regeneration. It establishes an integrative framework linking nanoparticle design, scaffold architecture, and biological response, highlighting how multifunctional systems can simultaneously eradicate tumors and promote tissue repair. Particular attention is given to nanoparticle–matrix interactions that modulate cell adhesion, differentiation, angiogenesis, and immune response, as well as to the influence of bioink composition—including polymeric, ceramic, hydrogel, and metallic systems—on the cellular microenvironment. The Outlook section discusses translational challenges such as vascularization, immunogenicity, scalability, and regulatory pathways, outlining future directions for the development of next-generation multimodal therapeutic scaffolds at the interface of nanomedicine and regenerative bioengineering.
癌症治疗通常会留下严重的组织损伤,因此迫切需要既能根除肿瘤又能使失去的组织再生的新策略。这篇综述探讨了纳米颗粒为基础的治疗与三维(3D)打印作为一个有前途的解决方案的整合。这种协同方法使用纳米粒子介导的癌症疗法,如光热疗法(PTT)和磁热疗(MHT),它们可以选择性地破坏肿瘤,同时也能够刺激血管生成和上调组织再生途径。该领域的大多数研究都集中在硬组织应用上,即骨;然而,最近在软组织,如皮肤和心肌的研究结果显示了更广泛的转化潜力。此外,支架内的免疫调节和基因治疗是具有巨大前景的新兴方向,但仍未得到充分探索。本文还讨论了当前的局限性,包括血管化不足、改进临床前模型的需要、可重复性挑战、可扩展性和监管障碍。通过巩固现有的证据,确定不发达的领域,并概述未来的方向,本综述提供了纳米颗粒结合的3d打印支架的协同癌症治疗和组织再生(TR)的全面和最新的评估。重要的是,该综述首次将PTT、MHT和TR系统地整合到一个统一的3d打印支架平台中,为指导该领域的未来发展提供了一个独特的视角。意义声明:这篇综述首次全面分析了结合纳米颗粒的3d打印支架用于联合癌症光疗、磁热疗和组织再生。它建立了一个连接纳米颗粒设计、支架结构和生物反应的综合框架,突出了多功能系统如何同时根除肿瘤和促进组织修复。特别关注纳米颗粒-基质相互作用,调节细胞粘附、分化、血管生成和免疫反应,以及生物连接成分(包括聚合物、陶瓷、水凝胶和金属系统)对细胞微环境的影响。展望部分讨论了转化方面的挑战,如血管化、免疫原性、可扩展性和调控途径,概述了纳米医学和再生生物工程界面下下一代多模态治疗支架的未来发展方向。
{"title":"3D printing of nanoparticle-containing scaffolds for cancer phototherapy, magnetic hyperthermia therapy, and tissue regeneration","authors":"Pedro D. Fernandes ,&nbsp;Filipa C. Silva ,&nbsp;Fernão D. Magalhães ,&nbsp;Rúben F. Pereira ,&nbsp;Susana G. Santos ,&nbsp;Artur M. Pinto","doi":"10.1016/j.actbio.2025.11.043","DOIUrl":"10.1016/j.actbio.2025.11.043","url":null,"abstract":"<div><div>Cancer therapies often leave behind significant tissue damage, creating a critical need for new strategies that can both eradicate tumors and simultaneously regenerate the lost tissues. This review explores the integration of nanoparticle-based treatments with three-dimensional (3D) printing as a promising solution. This synergistic approach uses nanoparticle-mediated cancer therapies, such as photothermal therapy (PTT) and magnetic hyperthermia (MHT), which can selectively destroy tumors while also being able to stimulate angiogenesis and upregulate tissue regenerative pathways. Most research in the field has focused on hard tissue applications, namely bone; however, recent outcomes in soft tissues, such as skin and myocardium, indicate broader translational potential. In addition, immunomodulation and gene therapy within scaffolds are emerging directions that hold great promise but remain underexplored. Current limitations are also discussed, including insufficient vascularization, the need for improved preclinical models, reproducibility challenges, scalability, and regulatory barriers. By consolidating current evidence, identifying underdeveloped areas, and outlining future directions, this review provides a comprehensive and up-to-date assessment of nanoparticle-incorporated 3D-printed scaffolds for synergistic cancer therapy and tissue regeneration (TR). Importantly, this review is the first to systematically integrate PTT, MHT, and TR within a unified 3D-printed scaffold platform, offering a distinct perspective that can guide future developments in the field.</div></div><div><h3>Statement of significance</h3><div>This review provides the first comprehensive analysis of 3D-printed scaffolds incorporating nanoparticles for combined cancer phototherapy, magnetic hyperthermia therapy, and tissue regeneration. It establishes an integrative framework linking nanoparticle design, scaffold architecture, and biological response, highlighting how multifunctional systems can simultaneously eradicate tumors and promote tissue repair. Particular attention is given to nanoparticle–matrix interactions that modulate cell adhesion, differentiation, angiogenesis, and immune response, as well as to the influence of bioink composition—including polymeric, ceramic, hydrogel, and metallic systems—on the cellular microenvironment. The Outlook section discusses translational challenges such as vascularization, immunogenicity, scalability, and regulatory pathways, outlining future directions for the development of next-generation multimodal therapeutic scaffolds at the interface of nanomedicine and regenerative bioengineering.</div></div>","PeriodicalId":237,"journal":{"name":"Acta Biomaterialia","volume":"210 ","pages":"Pages 221-279"},"PeriodicalIF":9.6,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145643653","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Electrowritten topographical conduit integrated with 4-octyl itaconate for peripheral nerve immunomodulation and regeneration 与4-辛酯衣康酸集成的电写地形导管用于周围神经免疫调节和再生。
IF 9.6 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2026-01-01 DOI: 10.1016/j.actbio.2025.11.052
De Bi , Yuye Huang , Lizhe He , Jinwen Jiang , Wenjie Chen , Kailei Xu , Peng Wei , Andong He , Jie Sun
Peripheral nerve injury (PNI) affects over one million individuals each year, resulting in persistent motor and sensory deficits and imposing substantial socioeconomic costs. Although autologous nerve grafting remains the gold standard, it is limited by donor site morbidity and incomplete functional recovery, and existing nerve conduits do not effectively modulate the early inflammatory response that impedes regeneration. Itaconic acid, a macrophage-specific metabolite, exhibits potent anti-inflammatory properties and therefore represents a promising candidate for promoting peripheral nerve repair. In this study, we fabricated a dual-layer nerve conduit (PCL+GelMA/4OI) by melt electrowriting (MEW) of polycaprolactone (PCL) microfibrous grids rolled into tubular scaffolds, followed by intraluminal injection of gelatin methacryloyl (GelMA) hydrogel encapsulating 4-octyl itaconate (4OI). In vitro assays demonstrated that 4OI inhibited TNF-α-induced activation of the NF-κB pathway in Schwann cells. The aligned MEW microfibers promoted neurite alignment along PCL fibers, while interfilamentous pores facilitated efficient mass transfer essential for nerve regeneration. In a rat sciatic nerve defect model, implantation of the PCL+GelMA/4OI conduit significantly reduced pro-inflammatory cytokine levels and improved electrophysiological recovery; histological analysis confirmed enhanced myelination and reduced muscle atrophy. Overall, this work presents a bifunctional strategy that combines topographical guidance with targeted immunomodulation, demonstrating that localized 4OI delivery synergistically accelerates nerve regeneration by attenuating inflammation and directing axonal growth.

Statement of significance

: Peripheral nerve injury (PNI) affects over one million individuals annually, often leading to lasting motor and sensory disabilities. While autologous nerve grafting is the standard treatment, it is limited by donor site morbidity and incomplete functional recovery. Current synthetic conduits fail to address the early inflammatory response, which hampers regeneration. To overcome these challenges, we developed a bifunctional nerve conduit that combines polycaprolactone (PCL) microfibers for topographical guidance with 4-octyl itaconate (4OI) for macrophage-specific immunomodulation. In vitro, 4OI inhibited TNF-α-induced NF-κB activation in Schwann cells, while in vivo, it reduced pro-inflammatory cytokines and improved electrophysiological recovery. The conduit promoted neurite alignment and enhanced myelination, demonstrating that targeted immunomodulation accelerates nerve regeneration through inflammation modulation and axonal guidance.
周围神经损伤(PNI)每年影响超过100万人,导致持续的运动和感觉缺陷,并造成巨大的社会经济成本。尽管自体神经移植仍然是金标准,但它受到供体部位发病率和功能恢复不完全的限制,并且现有的神经导管不能有效调节阻碍再生的早期炎症反应。衣康酸是一种巨噬细胞特异性代谢物,具有有效的抗炎特性,因此是促进周围神经修复的有希望的候选物质。在这项研究中,我们通过熔融电解(MEW)将聚己内酯(PCL)微纤维网格卷成管状支架,然后在腔内注射包封4-癸酸酯(4OI)的明胶甲基丙烯酰(GelMA)水凝胶,制备了双层神经导管(PCL+GelMA/4OI)。体外实验表明,4OI可抑制TNF-α-诱导的雪旺细胞NF-κB通路的激活。排列的MEW微纤维促进沿PCL纤维的神经突排列,而纤维间孔促进了神经再生所需的有效质量传递。在大鼠坐骨神经缺损模型中,植入PCL+GelMA/4OI导管可显著降低促炎细胞因子水平,促进电生理恢复;组织学分析证实髓鞘形成增强,肌肉萎缩减少。总的来说,这项工作提出了一种结合地形指导和靶向免疫调节的双功能策略,表明局部4OI递送通过减轻炎症和指导轴突生长来协同加速神经再生。意义声明:周围神经损伤(PNI)每年影响超过一百万人,通常导致持久的运动和感觉障碍。虽然自体神经移植是标准的治疗方法,但它受到供体部位发病率和功能恢复不完全的限制。目前的合成导管不能解决早期炎症反应,这阻碍了再生。为了克服这些挑战,我们开发了一种双功能神经导管,它结合了用于地形引导的聚己内酯(PCL)微纤维和用于巨噬细胞特异性免疫调节的4-伊康酸辛酯(4OI)。在体外,4OI可抑制TNF-α-诱导的雪旺细胞NF-κB活化,而在体内,4OI可降低促炎细胞因子,促进电生理恢复。导管促进神经突排列并增强髓鞘形成,表明靶向免疫调节通过炎症调节和轴突引导加速神经再生。
{"title":"Electrowritten topographical conduit integrated with 4-octyl itaconate for peripheral nerve immunomodulation and regeneration","authors":"De Bi ,&nbsp;Yuye Huang ,&nbsp;Lizhe He ,&nbsp;Jinwen Jiang ,&nbsp;Wenjie Chen ,&nbsp;Kailei Xu ,&nbsp;Peng Wei ,&nbsp;Andong He ,&nbsp;Jie Sun","doi":"10.1016/j.actbio.2025.11.052","DOIUrl":"10.1016/j.actbio.2025.11.052","url":null,"abstract":"<div><div>Peripheral nerve injury (PNI) affects over one million individuals each year, resulting in persistent motor and sensory deficits and imposing substantial socioeconomic costs. Although autologous nerve grafting remains the gold standard, it is limited by donor site morbidity and incomplete functional recovery, and existing nerve conduits do not effectively modulate the early inflammatory response that impedes regeneration. Itaconic acid, a macrophage-specific metabolite, exhibits potent anti-inflammatory properties and therefore represents a promising candidate for promoting peripheral nerve repair. In this study, we fabricated a dual-layer nerve conduit (PCL+GelMA/4OI) by melt electrowriting (MEW) of polycaprolactone (PCL) microfibrous grids rolled into tubular scaffolds, followed by intraluminal injection of gelatin methacryloyl (GelMA) hydrogel encapsulating 4-octyl itaconate (4OI). In vitro assays demonstrated that 4OI inhibited TNF-α-induced activation of the NF-κB pathway in Schwann cells. The aligned MEW microfibers promoted neurite alignment along PCL fibers, while interfilamentous pores facilitated efficient mass transfer essential for nerve regeneration. In a rat sciatic nerve defect model, implantation of the PCL+GelMA/4OI conduit significantly reduced pro-inflammatory cytokine levels and improved electrophysiological recovery; histological analysis confirmed enhanced myelination and reduced muscle atrophy. Overall, this work presents a bifunctional strategy that combines topographical guidance with targeted immunomodulation, demonstrating that localized 4OI delivery synergistically accelerates nerve regeneration by attenuating inflammation and directing axonal growth.</div></div><div><h3>Statement of significance</h3><div><strong>:</strong> Peripheral nerve injury (PNI) affects over one million individuals annually, often leading to lasting motor and sensory disabilities. While autologous nerve grafting is the standard treatment, it is limited by donor site morbidity and incomplete functional recovery. Current synthetic conduits fail to address the early inflammatory response, which hampers regeneration. To overcome these challenges, we developed a bifunctional nerve conduit that combines polycaprolactone (PCL) microfibers for topographical guidance with 4-octyl itaconate (4OI) for macrophage-specific immunomodulation. In vitro, 4OI inhibited TNF-α-induced NF-κB activation in Schwann cells, while in vivo, it reduced pro-inflammatory cytokines and improved electrophysiological recovery. The conduit promoted neurite alignment and enhanced myelination, demonstrating that targeted immunomodulation accelerates nerve regeneration through inflammation modulation and axonal guidance.</div></div>","PeriodicalId":237,"journal":{"name":"Acta Biomaterialia","volume":"210 ","pages":"Pages 280-295"},"PeriodicalIF":9.6,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145643681","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Modeling the human bladder tissue using three dimensional in vitro approaches as a tool for drug screening platforms 利用体外三维方法模拟人类膀胱组织,作为药物筛选平台的工具。
IF 9.6 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2026-01-01 DOI: 10.1016/j.actbio.2025.12.018
Daniel Carvalho , Soraia Pinto , Bruno Sarmento
The main function of bladder tissue is urine accumulation and excretion, and it is composed of five layers (mucus layer, epithelial layer, lamina propria, muscular layer, and perivesical tissue). Distinct conditions can compromise morphology and function of the bladder tissue, including congenital disorders, trauma, inflammation and/or cancer. Bladder cancer (BC) is one of the most common genitourinary tract complications, being classified as non-muscle invasive BC (NMIBC) or muscle-invasive BC (MIBC). NMIBC usually affects the mucosa and submucosa of the bladder tissue, requiring tumor resection, followed by intravesical administration of mitomycin-C. MIBC commonly affects the deeper layers of bladder, being associated with the origin of metastases, and it is recommended to perform a radical cystectomy followed by cisplatin-based neoadjuvant chemotherapy. In vitro techniques have been explored as drug screening platforms to test new therapeutic regimens, specifically 3D models that are gaining more attention with a wide range of applications. These 3D structures suitably recreate morphology, complexity and function of bladder tissue or tumor microenvironment (cell-cell and cell-extracellular matrix interactions). Additionally, 3D models represent a useful tool prior to in vivo assays. Different platforms can be developed for closer resembling in vivo urothelial epithelium and bladder tumor, and therefore, for studying tissue and/or tumor morphology, drugs permeability, among others. Following these purposes, 3D bladder models are already being designed, namely spheroids, multilayer models, organ-on-chip, bioprinting, and organoids. Hence, this review aims to highlight and summarize the current advances in the development of 3D in vitro bladder models.

Statement of Significance

Bladder cancer is classified as NMIBC or MIBC by tissue layer involvement. NMIBC and MIBC are treated with surgery and chemotherapy accordingly. 3D in vitro models accurately mimic bladder tissue and tumor environment. Organoids, spheroids, and hydrogels are established drug screening tools. 3D models show strong potential for translation into clinical applications.
膀胱组织的主要功能是尿液的蓄积和排泄,它由五层(黏液层、上皮层、固有层、肌肉层和膀胱周围组织)组成。一些特殊的情况会损害膀胱组织的形态和功能,包括先天性疾病、创伤、炎症和/或癌症。膀胱癌(BC)是最常见的泌尿生殖道并发症之一,分为非肌肉浸润性BC (NMIBC)和肌肉浸润性BC (MIBC)。NMIBC通常影响膀胱组织的粘膜和粘膜下层,需要肿瘤切除,然后膀胱内给予丝裂霉素c。MIBC通常影响膀胱的深层,与转移的起源有关,建议行根治性膀胱切除术,然后进行以顺铂为基础的新辅助化疗。体外技术已经被探索作为药物筛选平台来测试新的治疗方案,特别是3D模型,随着广泛的应用而受到越来越多的关注。这些3D结构适当地再现膀胱组织或肿瘤微环境(细胞-细胞和细胞-细胞外基质相互作用)的形态、复杂性和功能。此外,3D模型在体内分析之前是一个有用的工具。不同的平台可以开发更接近于体内尿路上皮和膀胱肿瘤,因此,研究组织和/或肿瘤形态,药物渗透性等。基于这些目的,3D膀胱模型已经被设计出来,即球体模型、多层模型、器官芯片、生物打印和类器官。因此,本文就体外膀胱三维模型的研究进展作一综述。意义声明:膀胱癌根据组织层累及分为NMIBC或MIBC。NMIBC和MIBC分别采用手术和化疗治疗。体外3D模型准确模拟膀胱组织和肿瘤环境。类器官、球体和水凝胶是公认的药物筛选工具。3D模型显示出转化为临床应用的强大潜力。
{"title":"Modeling the human bladder tissue using three dimensional in vitro approaches as a tool for drug screening platforms","authors":"Daniel Carvalho ,&nbsp;Soraia Pinto ,&nbsp;Bruno Sarmento","doi":"10.1016/j.actbio.2025.12.018","DOIUrl":"10.1016/j.actbio.2025.12.018","url":null,"abstract":"<div><div>The main function of bladder tissue is urine accumulation and excretion, and it is composed of five layers (mucus layer, epithelial layer, lamina propria, muscular layer, and perivesical tissue). Distinct conditions can compromise morphology and function of the bladder tissue, including congenital disorders, trauma, inflammation and/or cancer. Bladder cancer (BC) is one of the most common genitourinary tract complications, being classified as non-muscle invasive BC (NMIBC) or muscle-invasive BC (MIBC). NMIBC usually affects the mucosa and submucosa of the bladder tissue, requiring tumor resection, followed by intravesical administration of mitomycin-C. MIBC commonly affects the deeper layers of bladder, being associated with the origin of metastases, and it is recommended to perform a radical cystectomy followed by cisplatin-based neoadjuvant chemotherapy. <em>In vitro</em> techniques have been explored as drug screening platforms to test new therapeutic regimens, specifically 3D models that are gaining more attention with a wide range of applications. These 3D structures suitably recreate morphology, complexity and function of bladder tissue or tumor microenvironment (cell-cell and cell-extracellular matrix interactions). Additionally, 3D models represent a useful tool prior to <em>in vivo</em> assays. Different platforms can be developed for closer resembling <em>in vivo</em> urothelial epithelium and bladder tumor, and therefore, for studying tissue and/or tumor morphology, drugs permeability, among others. Following these purposes, 3D bladder models are already being designed, namely spheroids, multilayer models, organ-on-chip, bioprinting, and organoids. Hence, this review aims to highlight and summarize the current advances in the development of 3D <em>in vitro</em> bladder models.</div></div><div><h3>Statement of Significance</h3><div>Bladder cancer is classified as NMIBC or MIBC by tissue layer involvement. NMIBC and MIBC are treated with surgery and chemotherapy accordingly. 3D <em>in vitro</em> models accurately mimic bladder tissue and tumor environment. Organoids, spheroids, and hydrogels are established drug screening tools. 3D models show strong potential for translation into clinical applications.</div></div>","PeriodicalId":237,"journal":{"name":"Acta Biomaterialia","volume":"210 ","pages":"Pages 296-313"},"PeriodicalIF":9.6,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145746083","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Acta Biomaterialia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1